SEC Filing Details

Document Details

Form
Filing Date
Jun 10, 2019
Document Date
Jun 10, 2019
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Innate Pharma
Issuer
Innate Pharma SA